Press "Enter" to skip to content

Myriad Announces Publication of First Comprehensive Economic Study Demonstrating Cost Effectiveness of EndoPredict® for Breast Cancer – GlobeNewswire

admin 0

Myriad Announces Publication of First Comprehensive Economic Study Demonstrating Cost Effectiveness of EndoPredict® for Breast Cancer  GlobeNewswire

Findings Show EndoPredict Was Significantly More Cost Effective than Oncotype DX™

“breast cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *